Literature DB >> 10212240

CC chemokine receptor-3 undergoes prolonged ligand-induced internalization.

N Zimmermann1, J J Conkright, M E Rothenberg.   

Abstract

CC chemokine receptor-3 (CCR-3) is a major receptor involved in regulating eosinophil trafficking; therefore, elucidation of ligand-induced CCR-3 events has important implications in understanding the biological and pathological properties of eosinophils. Previous studies have demonstrated that unique receptor events occur in different cell types supporting investigation of CCR-3-mediated events in eosinophilic cells. We now report biochemical characterization of CCR-3 internalization following exposure of eosinophils to CCR-3 ligands. Treatment of freshly isolated human eosinophils with CCR-3 ligands resulted in marked and differential internalization of CCR-3 in a dose-dependent manner. Exposure to 100 ng/ml eotaxin reduced surface expression to 43, 43, and 76% at 15 min, 1 h, and 3 h, respectively. RANTES (reduced on activation T cell expressed and secreted) treatment induced more significant and prolonged internalization of CCR-3 than eotaxin; following 100 ng/ml of RANTES, 29, 24, and 47% of the receptor was expressed at 15 min, 3 h, and 18 h, respectively. Confocal microscopy demonstrated that receptor modulation involved receptor internalization by an endocytic pathway shared with the transferrin receptor. Receptor internalization was accompanied by partial degradation of CCR-3, and reexpression of CCR-3 was dependent in part upon de novo protein synthesis. Internalization was not blocked by pretreatment of eosinophils with pertussis toxin. Furthermore, staurosporine did not inhibit internalization although it blocked phorbol 12-myristate 13-acetate-induced CCR-3 down-modulation. These results demonstrate that CCR-3 ligands induce differential receptor internalization that is not dependent upon Gi-protein coupling, calcium transients, or protein kinase C.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10212240     DOI: 10.1074/jbc.274.18.12611

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Phosphorylation-independent association of CXCR2 with the protein phosphatase 2A core enzyme.

Authors:  G H Fan; W Yang; J Sai; A Richmond
Journal:  J Biol Chem       Date:  2001-02-26       Impact factor: 5.157

2.  HMGB1 contributes to allergen-induced airway remodeling in a murine model of chronic asthma by modulating airway inflammation and activating lung fibroblasts.

Authors:  Changchun Hou; Jinliang Kong; Yue Liang; Hong Huang; Hanchun Wen; Xiaowen Zheng; Lihong Wu; Yiqiang Chen
Journal:  Cell Mol Immunol       Date:  2014-08-25       Impact factor: 11.530

Review 3.  Overcoming hurdles in developing successful drugs targeting chemokine receptors.

Authors:  Thomas J Schall; Amanda E I Proudfoot
Journal:  Nat Rev Immunol       Date:  2011-04-15       Impact factor: 53.106

4.  Cannabinoids inhibit migration of microglial-like cells to the HIV protein Tat.

Authors:  Daniel Fraga; Erinn S Raborn; Gabriela A Ferreira; Guy A Cabral
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-07       Impact factor: 4.147

Review 5.  Chemokine receptor internalization and intracellular trafficking.

Authors:  Nicole F Neel; Evemie Schutyser; Jiqing Sai; Guo-Huang Fan; Ann Richmond
Journal:  Cytokine Growth Factor Rev       Date:  2005-07-05       Impact factor: 7.638

6.  Topical corticosteroids do not revert the activated phenotype of eosinophils in eosinophilic esophagitis but decrease surface levels of CD18 resulting in diminished adherence to ICAM-1, ICAM-2, and endothelial cells.

Authors:  Christine Lingblom; Henrik Bergquist; Marianne Johnsson; Patrik Sundström; Marianne Quiding-Järbrink; Mogens Bove; Christine Wennerås
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

7.  Association of eotaxin-2 gene polymorphisms with plasma eotaxin-2 concentration.

Authors:  Ji-Won Min; June-Hyuk Lee; Choon-Sik Park; Hun Soo Chang; Tai Youn Rhim; Sung-Woo Park; An-Soo Jang; Hyoung-Doo Shin
Journal:  J Hum Genet       Date:  2005-03-03       Impact factor: 3.172

8.  Ablation of type I hypersensitivity in experimental allergic conjunctivitis by eotaxin-1/CCR3 blockade.

Authors:  Dai Miyazaki; Takao Nakamura; Masaharu Ohbayashi; Chuan Hui Kuo; Naoki Komatsu; Keiko Yakura; Takeshi Tominaga; Yoshitsugu Inoue; Hidemitsu Higashi; Meguru Murata; Shuzo Takeda; Atsuki Fukushima; Fu-Tong Liu; Marc E Rothenberg; Santa Jeremy Ono
Journal:  Int Immunol       Date:  2009-01-15       Impact factor: 4.823

9.  Role of eotaxin-1 signaling in ovarian cancer.

Authors:  Vera Levina; Brian M Nolen; Adele M Marrangoni; Peng Cheng; Jeffrey R Marks; Miroslaw J Szczepanski; Marta E Szajnik; Elieser Gorelik; Anna E Lokshin
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

10.  CCR5 signalling, but not DARC or D6 regulatory, chemokine receptors are targeted by herpesvirus U83A chemokine which delays receptor internalisation via diversion to a caveolin-linked pathway.

Authors:  Julie Catusse; David J Clark; Ursula A Gompels
Journal:  J Inflamm (Lond)       Date:  2009-07-30       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.